Glenn Pierce's Net Worth
-$58.8 Thousand
Who is Glenn Pierce?
Glenn Pierce does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Voyager Therapeutics, Inc., Global Blood Therapeutics, Inc., and AVIGEN INC \DE.
SEC CIK
Glenn Pierce's CIK is 0001256964
Past Insider Trading and Trends
2020 was Glenn Pierce's most active year for acquiring shares with 6 total transactions. Glenn Pierce's most active month to acquire stocks was the month of May. 2022 was Glenn Pierce's most active year for disposing of shares, totalling 12 transactions. Glenn Pierce's most active month to dispose stocks was the month of September. 2020 saw Glenn Pierce paying a total of $225,450.00 for 47,884 shares, this is the most they've acquired in one year. In 2022 Glenn Pierce cashed out on 127,096 shares for a total of $63,730.40, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Voyager Therapeutics, Inc. (VYGR) Snapshot price: $6.13
Interim CSOGlenn Pierce owns 16,788 units of Common Stock which is worth $102,910.44. From 2017 to 2024 Glenn Pierce acquired a total of 26,300 shares in Voyager Therapeutics, Inc., Glenn also disposed a total of 9,512 shares of Voyager Therapeutics, Inc. equalling to $63,730.40.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
| -36.17% | -9.51K |
$6.70 | -$63,730.40 | 16.79K |
Scheduled
|
Jul 14
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
∞
| 26.3K |
—
|
—
| 26.3K |
Jan 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
∞
| 5K |
$18.44 | $92,200.00 | 5K |
Sep 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Global Blood Therapeutics, Inc. No price found
InvestorGlenn Pierce used to own units in Common Stock but no longer holds any shares there. In the year 2016 Glenn Pierce filed a total of 11 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -26.44K |
—
|
—
|
0
|
Oct 5
| |||
Form 4
| +15.76% | 3.6K |
—
|
—
| 26.44K |
Jun 14
| |||
Form 4
| +15.34% | 3.04K |
—
|
—
| 22.84K |
Jun 17
| |||
Form 4
| +312.50% | 15K |
$15.03 | $225,450.00 | 19.8K |
Sep 10
| |||
Form 4
|
∞
| 4.8K |
—
|
—
| 4.8K |
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AVIGEN INC \DE No price found
VP, Research & Clinical Dvlpt
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
| No matching records found | |||||||||